Navidea Biopharmaceutica Company Top Management
| NAVB Stock | USD 0.0001 0.00 0.00% |
Navidea Biopharmaceutica employs about 11 people. The company is managed by 3 executives with a total tenure of roughly 8 years, averaging almost 2.0 years of service per executive, having 3.67 employees per reported executive. Analysis of Navidea Biopharmaceutica's management performance can provide insight into the company performance.
| Jeffrey Smith Insider VP Operations |
| Erika Eves Insider VP Admin |
Navidea |
Navidea Biopharmaceutica Management Team Effectiveness
The company has return on total asset (ROA) of (1.2193) % which means that it has lost $1.2193 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (11.0012) %, meaning that it created substantial loss on money invested by shareholders. Navidea Biopharmaceutica's management efficiency ratios could be used to measure how well Navidea Biopharmaceutica manages its routine affairs as well as how well it operates its assets and liabilities.Navidea Biopharmaceutica maintains a total of 100.08 Million outstanding shares. Navidea Biopharmaceuticals holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in pink sheets such as Navidea Biopharmaceutica in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Navidea Biopharmaceutica, and when they decide to sell, the pink sheet will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Navidea Biopharmaceutica Workforce Comparison
Navidea Biopharmaceuticals is considered to be number one stock in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 143. Navidea Biopharmaceutica holds roughly 11.0 in number of employees claiming about 8% of equities under Health Care industry.
Navidea Biopharmaceutica Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Navidea Biopharmaceutica insiders, such as employees or executives, is commonly permitted as long as it does not rely on Navidea Biopharmaceutica's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Navidea Biopharmaceutica insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Scott John K Jr over a year ago Acquisition or disposition of Navidea Biopharmaceutica securities by Scott John K Jr | ||
Stefanelli Jill over a year ago Acquisition by Stefanelli Jill of 250000 shares of Navidea Biopharmaceutica subject to Rule 16b-3 |
Navidea Biopharmaceutica Notable Stakeholders
A Navidea Biopharmaceutica stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Navidea Biopharmaceutica often face trade-offs trying to please all of them. Navidea Biopharmaceutica's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Navidea Biopharmaceutica's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Jeffrey Smith | VP Operations | Profile | |
| Erika Eves | VP Admin | Profile | |
| Michael Rosol | Chief Medical Officer | Profile |
About Navidea Biopharmaceutica Management Performance
The success or failure of an entity such as Navidea Biopharmaceutica often depends on how effective the management is. Navidea Biopharmaceutica management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Navidea management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Navidea management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. Navidea Biopharmaceuticals, Inc. was incorporated in 1983 and is headquartered in Dublin, Ohio. Navidea Biopharmaceutica operates under Biotechnology classification in the United States and is traded on AMEX Exchange. It employs 11 people.
Please note, the presentation of Navidea Biopharmaceutica's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Navidea Biopharmaceutica's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Navidea Biopharmaceutica's management manipulating its earnings.
Navidea Biopharmaceutica Workforce Analysis
Traditionally, organizations such as Navidea Biopharmaceutica use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Navidea Biopharmaceutica within its industry.Navidea Biopharmaceutica Manpower Efficiency
Return on Navidea Biopharmaceutica Manpower
| Revenue Per Employee | 6K | |
| Revenue Per Executive | 21.9K | |
| Net Loss Per Employee | 1.4M | |
| Net Loss Per Executive | 5.1M |
Complementary Tools for Navidea Pink Sheet analysis
When running Navidea Biopharmaceutica's price analysis, check to measure Navidea Biopharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Navidea Biopharmaceutica is operating at the current time. Most of Navidea Biopharmaceutica's value examination focuses on studying past and present price action to predict the probability of Navidea Biopharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Navidea Biopharmaceutica's price. Additionally, you may evaluate how the addition of Navidea Biopharmaceutica to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |